CELEBRATION, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) Zevra Therapeutics (NASDAQ:ZVRA) ("Zevra" or "the Company"), a rare disease company melding science, data, and patient need to create transformational
Zevra Therapeutics (ZVRA) Appoints Thomas Anderson to Board of Directors and Announces Retirement of Matthew R Plooster streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) – Cantor Fitzgerald reduced their FY2023 earnings per share estimates for Zevra Therapeutics in a note issued to investors on Tuesday, May 16th. Cantor Fitzgerald analyst L. Chen now anticipates that the company will post earnings per share of ($1.45) for the year, down from their prior estimate […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) traded down 10% during trading on Tuesday . The stock traded as low as $4.41 and last traded at $4.43. 351,489 shares changed hands during mid-day trading, an increase of 51% from the average session volume of 233,420 shares. The stock had previously closed at $4.92. Analyst Upgrades […]
Zevra Therapeutics (ZVRA) Appoints Biopharma Veteran Wendy Dixon, Ph D , to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.